[{"Assets_0_Q3_USD":67709813.0,"CommonStockSharesOutstanding_0_Q3_shares":102689257.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-17390876.0,"NetIncomeLoss_1_Q3_USD":-7838873.0,"NetIncomeLoss_3_Q3_USD":-19503905.0,"StockholdersEquity_0_Q3_USD":64076598.0,"Ticker":"CPRX","CIK":"1369568","name":"CATALYST PHARMACEUTICALS, INC.","OfficialName":"Catalyst Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"872304311.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181107"}]